Chasing...... they do not approach Elite yet. They may have to in the future if laws are changed where companies have to license a technology IF they do not already have one of their own to use.
These companies will either have to license or lose market share when the FDA requires all prescription opioids have an ADF attached.
And this will benefit Elite when a buyout comes. Who gets Elite's ADF will get possible licensing of the ADF to other companies. Very lucrative indeed.
News 
Market Data 
Discover 
